BRIP1 and cancer: Second, although our work suggested that BRIP1 has the potential to be a diagnostic/prognostic biomarker for several certain cancers and could act as an effective target for immunotherapy in some tumors, further experiments in vitro/in vivo are required to verify these hypotheses.